# Gaius Therapeutics, Inc, — Form D

Gaius Therapeutics, Inc, of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-14. The offering totals $250K, of which $60K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-05-14
- Form: D
- Accession: 0002132841-26-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $60K
- Remaining: $190K
- Investors: 2
- Revenue range: Decline to Disclose
- SEC file number: 021-583983

## Issuer

- Name: Gaius Therapeutics, Inc,
- CIK: 0002132841
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9276 SCRANTON ROAD, SUITE 500 9276 Scranton Rd, Suite 500, SAN DIEGO, CA, 92121
- Phone: 650-255-8226

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Javid Aceil | Related Person | San Diego, CA |
| Christopher Emig | Related Person | San Diego, CA |
| Adam Klie | Related Person | San Diego, CA |
| Michon Pinnix | Related Person | San Diego, CA |
| Jesse Joseph Solvason | Related Person | San Diego, CA |
| Ben Wang | Related Person | San Diego, CA |

## More

- [CIK 2132841 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2132841&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002132841-26-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.